Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification.
作者： J. Röwert-Huber , M. J. Patel , T. Forschner , C. Ulrich , J. Eberle
DOI: 10.1111/J.1365-2133.2007.07860.X
关键词:
摘要: The term actinic keratosis (AK) describes a sun-induced, clinical erythematous lesion covered with scale, but does not provide an understanding of the biology or histopathology lesion. Consequently, several classification systems for AK have been suggested, as yet no consensus has reached. These strive to correlate pathological and features better physicians most accurate information enable correct decisions be made regarding treatments, Prognosis metastatic potential. is description that histological diagnosis consistent squamous cell carcinoma (SCC) in situ. We recommend system these lesions carcinomas (SCCs), using terminology 'early situ SCC Type I', type II' 'in III', there by giving clinicians guidance specific treatment recommendations.
elsevier.com
sci-hub.se 参考文章(154)
Kevin J. Ashton, Stephen R. Weinstein, David J. Maguire, Lyn R. Griffiths, Chromosomal Aberrations in Squamous Cell Carcinoma and Solar Keratoses Revealed by Comparative Genomic Hybridization Archives of Dermatology. ,vol. 139, pp. 876- 882 ,(2003) , 10.1001/ARCHDERM.139.7.876
E. Maubec, P. Duvillard, A. Margulis, B. Bachollet, G. Degois, M-F. Avril, Common skin cancers in porokeratosis British Journal of Dermatology. ,vol. 152, pp. 1389- 1391 ,(2005) , 10.1111/J.1365-2133.2005.06639.X
YOICHI MIZUTANI, HIROYUKI NAKANISHI, YONG NAN LI, NODOKA SATO, AKIHIRO KAWAUCHI, TSUNEHARU MIKI, Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522. The Journal of Urology. ,vol. 172, pp. 1474- 1479 ,(2004) , 10.1097/01.JU.0000131945.74377.AD
Robert G. Freeman, History of the American Society of Dermatopathology. American Journal of Dermatopathology. ,vol. 6, pp. 25- 33 ,(1984) , 10.1097/00000372-198402000-00008
N.H. Cox, D.J. Eedy, C.A. Morton, , Guidelines for management of Bowen's disease: 2006 update British Journal of Dermatology. ,vol. 156, pp. 11- 21 ,(2007) , 10.1111/J.1365-2133.2006.07610.X
Thierry Soussi, Christophe Béroud, Assessing TP53 status in human tumours to evaluate clinical outcome. Nature Reviews Cancer. ,vol. 1, pp. 233- 239 ,(2001) , 10.1038/35106009
C.J. Cockerell, Pathology and pathobiology of the actinic (solar) keratosis. British Journal of Dermatology. ,vol. 149, pp. 34- 36 ,(2003) , 10.1046/J.0366-077X.2003.05625.X
Robin Marks, George Rennie, ThomasS. Selwood, Malignant transformation of solar keratoses to squamous cell carcinoma. The Lancet. ,vol. 331, pp. 795- 797 ,(1988) , 10.1016/S0140-6736(88)91658-3
Heidemarie Kreimer-Erlacher, Hannes Seidl, Barbara Bäck, Helmut Kerl, Peter Wolf, High Mutation Frequency at Ha-ras Exons 1–4 in Squamous Cell Carcinomas from PUVA-treated Psoriasis Patients¶ Photochemistry and Photobiology. ,vol. 74, pp. 323- 330 ,(2001) , 10.1562/0031-8655(2001)074<0323:HMFAHR>2.0.CO;2
Kurt Gebauer, Pam Brown, George Varigos, Topical diclofenac in hyaluronan gel for the treatment of solar keratoses Australasian Journal of Dermatology. ,vol. 44, pp. 40- 43 ,(2003) , 10.1046/J.1440-0960.2002.00635.X